Todas las investigaciones
ReclutamientoOBSERVACIONAL

Giessen Pulmonary Hypertension in Lung Cancer Registry

This study, called the Giessen Pulmonary Hypertension in Lung Cancer Registry, aims to understand how common a condition called pulmonary hypertension is in people who have lung cancer. Pulmonary hypertension is when there's high blood pressure in the arteries that carry blood from your heart to your lungs. Doctors at Giessen University Hospital will collect information from all their lung cancer patients as part of their regular care. They want to see if there's a link between lung cancer and pulmonary hypertension. This is an observational study, which means no special treatments or tests will be given; doctors will simply use information they already gather during normal treatment. The goal is to learn more about this connection to help future patients.

De un vistazo

Estado
Reclutamiento
Patrocinador
University of Giessen
Objetivo de inscripción
500
Inicio
29 Jun 2020
Estimación de finalización
29 Jan 2040

¿De qué trata este estudio?

Doctors at Giessen University Hospital are running a study to learn more about lung cancer and a condition called pulmonary hypertension. Pulmonary hypertension means that the blood pressure in the special arteries that go from your heart to your lungs is too high. This can make your heart work harder and can sometimes cause breathlessness. The aim of this study is to see how often people with lung cancer also have pulmonary hypertension.

To do this, the research team will collect information from adult patients who are already being treated for lung cancer at their hospital. They'll look at routine health information that doctors already gather during your regular check-ups and treatments. They are not asking you to do any extra tests, appointments, or take new medicines. Everything will be based on your usual care.

This study is important because understanding if pulmonary hypertension commonly affects people with lung cancer could help doctors spot it earlier or manage care better in the future. By gathering this information, they hope to build a clearer picture of how these conditions might be connected and ultimately improve the health and well-being of lung cancer patients.

Puntos clave

  • This study looks at how often high blood pressure in the lungs (pulmonary hypertension) occurs in people with lung cancer.
  • It's a registry study, meaning doctors will collect information from existing patient records.
  • No extra tests, appointments, or treatments are involved.
  • Only adult lung cancer patients receiving care at Giessen University Hospital are included.
  • The aim is to improve understanding and potentially future care for lung cancer patients.
  • Your medical care will not be affected by participating.

¿Quién puede ser elegible?

To be part of this study, you need to be an adult patient (aged 18 or older) who is currently receiving treatment for lung cancer at the University of Giessen Lung Cancer Center.

There are no specific reasons why someone would be excluded from participating, as long as they meet the main requirement of being a lung cancer patient at this particular hospital.

¿Podría este estudio ser adecuado para ti?

Responde estas preguntas rápidas para ver si puedes ser elegible. Esto es solo una guía: el equipo de investigación toma la decisión final.

  1. ¿Tengo 18 años o más?
  2. Do I have lung cancer?
  3. Am I being treated for lung cancer at the University of Giessen Lung Cancer Center?
  4. Do I understand that no extra tests or treatments are involved?
Responde cada pregunta para ver tu resultado.

¿En qué consiste la participación?

If you are a lung cancer patient at Giessen University Hospital and decide to take part in this registry study, you won't need to do anything extra. There are no additional visits, special tests, or new medications involved. The study will simply use information that your doctors already collect during your regular course of treatment for lung cancer. This means your care will stay exactly the same, whether you participate or not. The researchers will look at your existing medical records to understand more about pulmonary hypertension in lung cancer patients.

Riesgos y beneficios potenciales

Since this study only involves looking at information from your existing medical records, there are no direct physical risks to you. Your personal information will be kept private and handled carefully. The main benefit is that your information, combined with that of many other patients, could help doctors learn more about how lung cancer and pulmonary hypertension are linked. This knowledge could lead to better understanding and possibly better care for future patients. You are always free to decide not to have your information used in this study without it affecting your medical care in any way.

Ubicaciones (1)

  • University hospital Giessen
    Código postal verificado
    Giessen, Germany· Reclutamiento

Preguntas comunes

What is pulmonary hypertension?

Pulmonary hypertension means you have high blood pressure in the arteries that carry blood from your heart to your lungs.

Will I have to take new medicine?

No, this study doesn't involve any new medicines, treatments, or extra tests. Your care will be exactly as it is now.

Will this study change my lung cancer treatment?

No, this study is about collecting information; it will not change your current lung cancer treatment or care plan at all.

¿Quién puede unirse a este estudio?

Adult patients (18 and older) who are being treated for lung cancer at Giessen University Hospital can be included.

¿Se mantendrá privada mi información?

Yes, all your health information used in this study will be kept confidential and handled securely.

Cómo obtener más información

Bastian Eul, MD

Siempre hable con su médico de cabecera o especialista antes de decidir participar en un estudio.

¿Interesado en participar?

Registra tu interés

Comparte tus detalles y el equipo de investigación para "Giessen Pulmonary Hypertension in Lung Cancer Registry…" se pondrá en contacto contigo si puedes ser elegible. Siempre habla con tu médico antes de aceptar participar.

Discusión

Discusión comunitaria

Impulsado por nuestro foro en community.patient.info. Por favor, sea respetuoso — esto no es un consejo médico.